COUAA202_2: COUAA202, figure 2

COUAA202_2R Documentation

COUAA202, figure 2

Description

Kaplan-Meier digitized data from COUAA202, figure 2 (PMID 25601341). A reported sample size of 1,088 for a primary endpoint of rPFS/OS in prostate cancer.

Usage

COUAA202_2

Format

A data frame of 1,088 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (abiraterone, placebo)

Source

Ryan CJ, Smith MR, Fizazi K, et al. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 2015; 16: 152–60.

Examples

summary(COUAA202_2)

kmplot(COUAA202_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.